Clinical Trial

Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine whether Sirolimus is more effective and burdened with less side effects than conventional treatment with corticosteroids in patients with active thyroid eye disease.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-06-16; most recent amendment 2025-09-19.
Status change: Not Yet Recruiting → Recruiting 2023-03-02
Trial Details
NCT Number NCT04936854
Lead Sponsor Haukeland University Hospital
Conditions Thyroid-Associated Ophthalmopathy
Enrollment 60 participants
Start Date 2023-01-01
Primary Completion 2028-01 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-22